Coronary stent implantation for acute basilar artery occlusion with underlying stenosis

Sándor Nardai1, Balázs Kis, István Gubucz

  • 1Department Section of Neurointervention, Semmelweis University Department of Neurosurgery, National Institute of Clinical Neurosciences, Budapest, Hungary.

Insights

Coronary stent implantation during endovascular treatment for basilar artery occlusion with intracranial atherosclerotic stenosis improves survival and functional outcomes. This intervention reduces residual stenosis and enhances recovery chances.

Area of Science:

  • Neuroendovascular therapy
  • Cerebrovascular diseases
  • Interventional neurology

Background:

  • Acute basilar artery occlusion (BAO) with underlying intracranial atherosclerotic stenosis (ICAS) presents significant challenges.
  • Standard endovascular treatment (EVT) outcomes for BAO with ICAS are often suboptimal.

Purpose of the Study:

  • To evaluate the effectiveness of immediate coronary stent implantation during EVT for BAO with ICAS.
  • To assess the impact of stenting on clinical outcomes, including survival and functional recovery.

Main Methods:

  • Retrospective analysis of 91 BAO patients undergoing EVT.
  • Comparison of outcomes between patients with and without ICAS.
  • Assessment of stenting versus non-stenting in BAO-ICAS patients.

Main Results:

  • BAO patients with ICAS had longer reperfusion times, lower reperfusion rates, and higher mortality compared to those without ICAS.
  • Stenting in BAO-ICAS patients significantly reduced residual stenosis.
  • Patients treated with stents showed higher chances of functional recovery and survival.

Conclusions:

  • Immediate coronary stent implantation in BAO with underlying ICAS improves overall survival.
  • Stenting combined with dual antiplatelet therapy (DAPT) leads to better functional outcomes in these patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
868
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
283
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
372